Highlights the rare but life-threatening risk of neuroleptic malignant syndrome even with newer antipsychotic drugs like risperidone and quetiapine.
Raises caution for NMS with risperidone-quetiapine coadministration; leaves open need for systematic safety data.
Neuroleptic malignant syndrome (NMS) is a rare but life-threatening condition induced by neuroleptic medications. In severe cases, NMS can rapidly lead to death. NMS is reported less frequently now-a-days with the advent of new antipsychotic drugs. We discuss 20-year-old male patient with NMS induced by risperidone and quetiapin.
No takes yet. Share an insight, caveat, or question.
Demir et al. (2016) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: